Form D · Pharmaceuticals
BiologicsMD, Inc.
Fayetteville, AR · CIK 0001508176
Offering snapshot reported Feb 8, 2016 · SEC filing
- Reported sold
- $400K Offering amount: $7M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 1, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 8, 2016 | Initial | $400,000 | No comparison | 1 | SEC filing |
| Jan 10, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-256949
Source: Form D, filed Feb 8, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ramsay Ball | Director |
| Clete Brewer | Director |
| Rob Gensure | Executive |
| Rob Gensure, Md, Ph D | Executive |
| Calvin Goforth | Director, Promoter |
| Robyn Goforth | Executive |
| Robyn Goforth, Ph D | Executive |
| Calvin Goforth, Ph D | Director, Promoter |
| Lynn Kirkpatrick | Director |
| Paul Mlakar, Jr. | Director, Executive, Promoter |
| J. David Owens | Director, Executive |
| Jim Shook, Ph D | Executive |
| Misty Stevens, Ph D | Executive |
| Michael Thomas | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
535 W. Research Center Blvd #135
Fayetteville, AR, 72701
Fayetteville, AR, 72701